A systematic review of neurocognitive dysfunction with overactive bladder medications-Reference-Cited by-同舟云学术

A systematic review of neurocognitive dysfunction with overactive bladder medications

Published:2021-07-02 Issue:10 Volume:32 Page:2693-2702
ISSN:0937-3462
Container-title:International Urogynecology Journal
language:en
Short-container-title:Int Urogynecol J

Author:

Duong Vi^ORCID,Iwamoto Aya,Pennycuff Jon,Kudish Bela,Iglesia Cheryl

Publisher

Springer Science and Business Media LLC

Subject

Urology,Obstetrics and Gynecology

Link

https://link.springer.com/content/pdf/10.1007/s00192-021-04909-5.pdf

Reference38 articles.

1. Haylen BT, De Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21(1):5–26.

2. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–36.

3. Ju R, Garrett J, Wu JM. Anticholinergic medication use for female overactive bladder in the ambulatory setting in the United States. Int Urogynecol J. 2014;25(4):479–84.

4. Ageing and health [WHO Web site]. February 5, 2018. Available at: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health. Accessed December 1, 2020.

5. Gormley EA, Lightner DJ, Faraday M, Vasavada S. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol. 2015;193(5):1572–80.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-hormonal pharmacological interventions for managing vasomotor symptoms-how can we help: 2024 landscape;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-11

2. Frailty, Specialized Care, and Sociodemographic Factors: Disparities in Oral Pharmacotherapy Class Utilization Among Medicare Part D Beneficiaries With Overactive Bladder in the United States;Urology;2024-09

3. Management of the Vasomotor Symptoms of Menopause: Twofers in Your Clinical Toolbox;Mayo Clinic Proceedings;2024-07

4. In Silico Electrophysiological Investigation of Transient Receptor Potential Melastatin-4 Ion Channel Biophysics to Study Detrusor Overactivity;International Journal of Molecular Sciences;2024-06-22

5. Urinary Incontinence Medications: Patient-Initiated Concerns in Primary Care;Urogynecology;2024-06-21